Supportive Care in Cancer

, Volume 15, Issue 8, pp 985–992 | Cite as

The impact of acculturation on the use of traditional Chinese medicine in newly diagnosed Chinese cancer patients

  • Mark Anthony Ferro
  • Anne Leis
  • Richard Doll
  • Lyren Chiu
  • Michael Chung
  • Maria-Cristina Barroetavena
Original Article

Abstract

Goals of work

This study assessed the impact of acculturation on the prevalence of traditional Chinese medicine and other complementary and alternative medicine (TCM/CAM) use in newly diagnosed Chinese cancer patients. The individual determinants of TCM/CAM use among patients were also investigated.

Materials and methods

A consecutive sample of Chinese cancer patients treated at the British Columbia Cancer Agency was surveyed at admission using a 15-item questionnaire. Items included TCM/CAM use, sociodemographics, as well as medical and cultural factors. Data were analyzed using bivariate methods including Pearson’s X2 test and Student’s t test. As well, multiple logistic regression was used to obtain the final causal model.

Main results

Of the 230 respondents, 57% completed the survey in Chinese and 94% were immigrants. The average age was 59. Participants had a mean disease duration of approximately 2 months and 79% had already received at least one conventional treatment. Overall, TCM/CAM was used by 47% of respondents. Herbal remedies, vitamins/minerals, and prayer were the most commonly used therapies. Multivariable analysis showed that prior TCM/CAM use (p < 0.001), having received conventional treatment(s) (p = 0.029), and being less acculturated (p = 0.028) were associated with TCM/CAM use.

Conclusions

Prevalence and type of use were found to vary as a function of the degree of acculturation. Health care practitioners would be well advised to discuss TCM/CAM use with their patients, especially those who are less acculturated to Western society, since they are the most likely users of TCM/CAM.

Keywords

Acculturation Cancer Chinese Complementary and alternative medicine Traditional Chinese medicine 

Notes

Acknowledgements

We acknowledge Drs. Stephen Lam and John Yun for their support of this study. We also thank Ms.Yuan Lai, Ms. Diane Skippen, and Mr. Hansen Chou for coordinating the study and collecting data. We are grateful to the British Columbia Cancer Agency reception staff for their support and Mr. Tong Zhu for helping with the interpretation of data in Chinese. Our special thanks go to Ms. Jennifer Millard who offered very competent administrative support throughout the study. This research was funded by a grant to AL from the Canadian Institutes for Health Research, Palliative Care in a Cross-Cultural Context New Emerging Team (PET 69768) for equitable and quality cancer care for culturally diverse populations.

References

  1. 1.
    Abdullah AS, Lau Y, Chow LW (2003) Pattern of alternative medicine usage among the Chinese breast cancer patients: implication for service integration. Am J Chin Med 31:649–658PubMedCrossRefGoogle Scholar
  2. 2.
    Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548PubMedCrossRefGoogle Scholar
  3. 3.
    Beach MC, Price EG, Gary TL, Robinson KA, Gozu A, Palacio A, Smarth C, Jenckes MW, Feuerstein C, Bass EB, Powe NR, Cooper LA (2005) Cultural competence: a systematic review of health care provider educational interventions. Med Care 43:356–373PubMedCrossRefGoogle Scholar
  4. 4.
    Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A, Brown JB, Goel V (2003) Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 62:849–853PubMedCrossRefGoogle Scholar
  5. 5.
    Boon H, Wong J (2004) Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 5:2485–2501PubMedCrossRefGoogle Scholar
  6. 6.
    Cao QZ, Lin ZB (2006) Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 78:1457–1463PubMedCrossRefGoogle Scholar
  7. 7.
    Chan CW, Hon HC, Chien WT, Lopez V (2004) Social support and coping in Chinese patients undergoing cancer surgery. Cancer Nurs 27:230–236PubMedCrossRefGoogle Scholar
  8. 8.
    Chen WT, Bakken S (2004) Breast cancer knowledge assessment in female Chinese immigrants in New York. Cancer Nurs 27:407–412PubMedCrossRefGoogle Scholar
  9. 9.
    Chiu L, Balneaves L, Barroetavena MC, Doll R, Leis A (2006) Use of complementary and alternative medicine by Chinese individuals living with cancer in British Columbia. J Complement Integr Med 3:2Google Scholar
  10. 10.
    Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, Zheng W (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85:263–270PubMedCrossRefGoogle Scholar
  11. 11.
    Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2:212–216PubMedCrossRefGoogle Scholar
  12. 12.
    Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134–138PubMedCrossRefGoogle Scholar
  13. 13.
    Gao Y, Zhou S, Jiang W, Huang M, Dai X (2003) Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32:201–215PubMedCrossRefGoogle Scholar
  14. 14.
    Gotay CC, Hara W, Issell BF, Maskarinec G (1999) Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J 58:94–98PubMedGoogle Scholar
  15. 15.
    Gotay CC, Muraoka M, Holup J (2001) Cultural aspects of cancer prevention and control. In: Kazarian SS, Evans DR (eds) Handbook of cultural psychology. Academic Press, San Diego, CAGoogle Scholar
  16. 16.
    Health-Canada (2007) List of Licensed Natural Health Products. Retrieved Jun 4, 2007, from http://www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/lists/listapprnhp-listeapprpsn_e.html
  17. 17.
    Hislop TG, Deschamps M, Teh C, Jackson C, Tu SP, Yasui Y, Schwartz SM, Kuniyuki A, Taylor V (2003) Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Can J Public Health 94:68–73PubMedGoogle Scholar
  18. 18.
    Ho RT, Chan CL, Ho SM (2004) Emotional control in Chinese female cancer survivors. Psychooncology 13:808–817PubMedCrossRefGoogle Scholar
  19. 19.
    Jiang J, Slivova V, Sliva D (2006) Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29:695–703PubMedGoogle Scholar
  20. 20.
    Jones EG, Kay M (1992) Instrumentation in cross-cultural research. Nurs Res 41:186–188PubMedGoogle Scholar
  21. 21.
    Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Tasaki K (2003) Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis. Soc Sci Med 56:851–862PubMedCrossRefGoogle Scholar
  22. 22.
    Kleinman AM (1973) Toward a comparative study of medical systems: an integrated approach to the study of the relationship of medicine and culture. Sci Med Man 1:55–65PubMedGoogle Scholar
  23. 23.
    Kronenberg F, Cushman LF, Wade CM, Kalmuss D, Chao MT (2006) Race/ethnicity and women’s use of complementary and alternative medicine in the United States: results of a national survey. Am J Public Health 96:1236–1242PubMedCrossRefGoogle Scholar
  24. 24.
    Kwok Y, Ng KF, Li CC, Lam CC, Man RY (2005) A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg 101:423–426PubMedCrossRefGoogle Scholar
  25. 25.
    Lapine A, Wang-Cheng R, Goldstein M, Nooney A, Lamb G, Derse AR (2001) When cultures clash: physician, patient, and family wishes in truth disclosure for dying patients. J Palliat Med 4:475–480PubMedCrossRefGoogle Scholar
  26. 26.
    Lee EH, Kim JS, Song MS (2002) Translation and validation of champion’s health belief model scale with Korean women. Cancer Nurs 25:391–395PubMedCrossRefGoogle Scholar
  27. 27.
    Lee MM, Chang JS, Jacobs B, Wrensch MR (2002) Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92:1606–1609PubMedCrossRefGoogle Scholar
  28. 28.
    Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47PubMedCrossRefGoogle Scholar
  29. 29.
    Li-chun C, I-chuan L (2004) Patterns of complementary therapy use by homebound cancer patients in Taiwan. Appl Nurs Res 17:41–47PubMedCrossRefGoogle Scholar
  30. 30.
    Liu JM, Chu HC, Chin YH, Chen YM, Hsieh RK, Chiou TJ, Whang-Peng J (1997) Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 27:37–41PubMedCrossRefGoogle Scholar
  31. 31.
    Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP, Rao JY (2004) Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216:9–20PubMedCrossRefGoogle Scholar
  32. 32.
    Mak MH (2001) Awareness of dying: an experience of Chinese patients with terminal cancer. Omega 43:259–279PubMedGoogle Scholar
  33. 33.
    Maskarinec G, Shumay DM, Kakai H, Gotay CC (2000) Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med 6:531–538PubMedGoogle Scholar
  34. 34.
    McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12:454–462PubMedCrossRefGoogle Scholar
  35. 35.
    McKay DJ, Bentley JR, Grimshaw RN (2005) Complementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Can 27:562–568PubMedGoogle Scholar
  36. 36.
    Messias DK, Rubio M (2004) Immigration and health. Annu Rev Nurs Res 22:101–134PubMedGoogle Scholar
  37. 37.
    Miller LG (1998) Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200–2211PubMedCrossRefGoogle Scholar
  38. 38.
    National Cancer Institute of Canada (NCIC) (2006) Canadian cancer statistics, 2006. NCIC, CanadaGoogle Scholar
  39. 39.
    Nonaka Y, Shibata H, Nakai M, Kurihara H, Ishibashi H, Kiso Y, Tanaka T, Yamaguchi H, Abe S (2006) Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci Biotechnol Biochem 70:2028–2034PubMedCrossRefGoogle Scholar
  40. 40.
    Oliffe J, Thorne S, Hislop TG, Armstrong EA (2007) “Truth telling” and cultural assumptions in an era of informed consent. Fam Commun Health 30:5–15Google Scholar
  41. 41.
    Philip RB (2004) Herbal remedies: the good, the bad, and the ugly. J Complement Integr Med 1:1–11Google Scholar
  42. 42.
    Pineda MD, White E, Kristal AR, Taylor V (2001) Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol 30:976–982PubMedCrossRefGoogle Scholar
  43. 43.
    Rosner B (2000) Fundamentals of biostatistics, 5th edn. Duxbury, Pacific GroveGoogle Scholar
  44. 44.
    Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, PhiladelphiaGoogle Scholar
  45. 45.
    Salant T, Lauderdale DS (2003) Measuring culture: a critical review of acculturation and health in Asian immigrant populations. Soc Sci Med 57:71–90PubMedCrossRefGoogle Scholar
  46. 46.
    Satia-Abouta J, Patterson RE, Kristal AR, Teh C, Tu SP (2002) Psychosocial predictors of diet and acculturation in Chinese American and Chinese Canadian women. Ethn Health 7:21–39PubMedCrossRefGoogle Scholar
  47. 47.
    Shen J, Glaspy J (2001) Acupuncture: evidence and implications for cancer supportive care. Cancer Pract 9:147–150PubMedCrossRefGoogle Scholar
  48. 48.
    Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, Shekelle PG (2000) Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 284:2755–2761PubMedCrossRefGoogle Scholar
  49. 49.
    Shih FJ (1996) Concepts related to Chinese patients’ perceptions of health, illness and person: issues of conceptual clarity. Accid Emerg Nurs 4:208–215PubMedCrossRefGoogle Scholar
  50. 50.
    Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2:358–364PubMedCrossRefGoogle Scholar
  51. 51.
    Stanley G, Harvey K, Slivova V, Jiang J, Sliva D (2005) Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330:46–52PubMedCrossRefGoogle Scholar
  52. 52.
    Statistics-Canada (2005) Study: Canada’s visible minority population in 2017 (No. 91-541-XIE). Statistics-Canada, OttawaGoogle Scholar
  53. 53.
    Suinn RM, Ahuna C, Khoo G (1992) The Suinn-Lew Asian Self-Identity Acculturation Scale: concurrent and factorial validation. Educ Psychol Meas 52:1041–1046CrossRefGoogle Scholar
  54. 54.
    Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80:205–211PubMedCrossRefGoogle Scholar
  55. 55.
    Thyagarajan A, Jiang J, Hopf A, Adamec J, Sliva D (2006) Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18:657–664PubMedGoogle Scholar
  56. 56.
    Tough SC, Johnston DW, Verhoef MJ, Arthur K, Bryant H (2002) Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med 8:54–56, 58–60, 62–54PubMedGoogle Scholar
  57. 57.
    Geertz as cited in Turner L (2005) From the local to the global: bioethics and the concept of culture. J Med Philos 30:305–320Google Scholar
  58. 58.
    Wendler D, Cornelio M (2006) Overcoming language barriers in medical care. Pediatr Blood Cancer 47:747PubMedCrossRefGoogle Scholar
  59. 59.
    Xu W, Towers AD, Li P, Collet JP (2006) Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. Eur J Cancer Care (Engl) 15:397–403CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Mark Anthony Ferro
    • 1
    • 6
  • Anne Leis
    • 1
  • Richard Doll
    • 2
  • Lyren Chiu
    • 4
  • Michael Chung
    • 5
  • Maria-Cristina Barroetavena
    • 3
  1. 1.Department of Community Health and EpidemiologyUniversity of SaskatchewanSaskatoonCanada
  2. 2.Sociobehavioural Research CentreBritish Columbia Cancer AgencyVancouverCanada
  3. 3.Department of Health Care and EpidemiologyUniversity of British ColumbiaVancouverCanada
  4. 4.School of NursingUniversity of British ColumbiaVancouverCanada
  5. 5.AMBER TCM Healing CentreWest VancouverCanada
  6. 6.Department of Epidemiology and BiostatisticsUniversity of Western OntarioLondonCanada

Personalised recommendations